Botanix Pharmaceuticals Limited

ASX:BOT

Botanix Pharmaceuticals Limited

ASX:BOT
TradeAdd trade order Follow Unfollow Set Price Alert
$0.215 (0%)
Last close price
#24
Rank
14
Held by
21
Followers
TradeAdd trade order Follow Unfollow Set Price Alert
Reports (1) My Report Forum Investors
Top member reports
Consensus
mmff
Company Report
Last edited 3 years ago
PerformanceCommunity EngagementCommunity Endorsement
ranked
#169
Performance (44m)
-18.0% pa
Followed by
156
Follow Unfollow
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
Become a member
#Study Results #2A 3/2/21
stale
mmff
Added 3 years ago
View author's company report

Phase 2a Study Shows BTX 1801 Eradicates Staphylococcus Aureus

• Top-line data showed that two different BTX 1801 formulations (ointment and gel) were safe, well tolerated and successful at eradicating Staphylococcus aureus.

• Eradication rates as high as 76.2% were obtained at Day 7 for BTX 1801 ointment, with eradication effects extending through to Day 28 of the study to 23.8%, despite no treatment after Day 5

• Botanix continues to assess the clinical utility of synthetic CBD for the treatment of a variety of infections and also develop its proprietary CBD analog assets

View Attachment